eoadjuvant chemotherapy in gastric adenocarcinoma
- Conditions
- Gastric adenocarcinoma.Malignant neoplasm of stomach
- Registration Number
- IRCT2014053113736N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
1) Age between 18-70 years old
2) Confirmation of gastric adenocarcinoma by endoscopic sampling and histopathological analysis
3) Confirmation of locally-advanced disease by preoperative computed tomography
4) Confirmation of resectability by preoperative computed tomography
Exclusion criteria:
1) Ages older than 70
2) Gastric malignancies other than adenocarcinoma
3) Distant metastasis in preoperative assessment
4) Any contraindication to chemotherapy
5) History of previous chemotherapy
6) History of previous radiotherapy
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reseactability. Timepoint: Intraoperative (After chemotherapy in case group and after diagnosis in control group). Method of measurement: Intraoperative findings.
- Secondary Outcome Measures
Name Time Method ocal lymph node regression. Timepoint: After neoadjuvant chemotherapy (6 weeks). Method of measurement: Computed tomography.